If creatinine already underestimates the risk of CKD, then the potential implications with iohexol and cystatin C (potentially an even higher incidence rate) are even more concerning, further underscoring the urgency of addressing CKD as a public concern. This evidence concerns the gene CST3 and chronic kidney disease.